ETF Managers Group’s Maravai LifeSciences MRVI Stock Holding History

ETF Managers Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-31,803	Closed	-$455K	–	717
2022 Q4	$455K	Buy	31,803 +12,410	+64%	+$195K	0.02%	381
2022 Q3	$495K	Buy	+19,393	New	+$487K	0.02%	431

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

ETF Managers Group's MRVI Position: Q1 2023 in Review

ETF Managers Group sold out of Maravai LifeSciences (MRVI) in Q1 2023, closing a stake of 31,803 shares — an estimated $455K sold.

ETF Managers Group first reported a position in MRVI in Q3 2022 and held it in 2 quarters. The position peaked at $495K in Q3 2022. 220 funds tracked by Wall St. Rank hold MRVI as of Q1 2023.

ETF Managers Group reported no remaining Maravai LifeSciences position as of Q1 2023 after selling out during the quarter.
ETF Managers Group sold 31,803 Maravai LifeSciences shares in Q1 2023, an estimated $455K.
ETF Managers Group first reported a position in Maravai LifeSciences in Q3 2022 and held it in 2 quarters.
ETF Managers Group's Maravai LifeSciences position peaked at $495K in Q3 2022.
220 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.